Taige

Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) is a leading global Contract Research Organization (CRO) headquartered in China, specializing in comprehensive R&D services for the pharmaceutical, biotech, and medical device industries. The company provides a full suite of clinical trial solutions, including clinical operation, regulatory affairs, data management, statistical analysis, and medical imaging. Tigermed is recognized as the largest clinical CRO in China, offering extensive expertise in navigating the region's complex regulatory environment and patient recruitment landscape. Through its global network and subsidiaries like Frontage Holdings and DreamCIS, the company supports drug development across all clinical phases and therapeutic areas. Tigermed is publicly traded on both the Shenzhen and Hong Kong stock exchanges, serving a global client base that includes major multinational pharmaceutical companies and emerging biotechs.